Financial statements Inovamed
Balance sheet data of INOVAMED
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 4 006 358,09 | 3 713 994,31 | 4 137 536,78 | 4 480 900,92 | 5 235 216,81 |
| A. Fixed assets | 1 507 044,94 | 1 256 565,15 | 792 476,97 | 931 245,12 | 585 876,66 |
| B. Current assets | 2 499 313,15 | 2 457 429,16 | 3 345 059,81 | 3 549 655,80 | 4 649 340,15 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 4 006 358,09 | 3 713 994,31 | 4 137 536,78 | 4 480 900,92 | 5 235 216,81 |
| A. Equity | 2 027 411,57 | 1 670 363,55 | 1 744 912,46 | 2 220 549,21 | 2 997 206,48 |
| B. Liabilities and provisions for liabilities | 1 978 946,52 | 2 043 630,76 | 2 392 624,32 | 2 260 351,71 | 2 238 010,33 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 1 584 598,04 | 1 814 910,83 | 1 664 821,52 | 1 276 088,15 | 1 347 899,66 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.